Should You Buy Novavax Stock After This Regulatory Win?
The biotech continues to earn important wins, but is it enough?
| Ticker |
Sentiment |
Impact |
|
NVAX
|
Somewhat Bullish
|
78 %
|
|
MRNA
|
Somewhat Bullish
|
7 %
|
|
PFE
|
Somewhat Bullish
|
7 %
|
|
BNTX
|
Somewhat Bullish
|
7 %
|
|
SNY
|
Somewhat Bullish
|
49 %
|
